Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human SNAP25 ELISA Kit (AC3302)
Cat.#: ASET-1891
Specifications
Description Human SNAP25 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SNAP25 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.023 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2211 Mouse Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3622) Quantitative inquiry ASET-1437 Human Wnt3 ELISA Kit (AC2848) Quantitative inquiry ASET-2351 Human SNAP25 ELISA Kit (AC3762) Quantitative inquiry ASET-1711 Human APLP1 ELISA Kit (AC3122) Quantitative inquiry ASET-2388 Rabbit CRH ELISA Kit (AC3799) Quantitative inquiry ASET-2499 Human Galanin ELISA Kit (AC3910) Quantitative inquiry ASET-1887 Mouse Mtnr1a ELISA Kit (AC3298) Quantitative inquiry ASET-1833 Human Ferritin Heavy Chain ELISA Kit (AC3244) Quantitative inquiry ASET-2357 Human GBA ELISA Kit (AC3768) Quantitative inquiry ASET-1224 Human HIP1 ELISA Kit (AC2635) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket